Clinical Trials Browser

Phase 2 × Melanoma × fluoromisonidazole × Clear all

NCT02061007 2016-05-09

Biomarker Correlates of Hypoxia in Metastatic Melanoma

Phase 2 Withdrawn

Melanoma, Skin Neoplasms